IDH2 p.R172M

Biomarker type: Somatic variant

Gene context: IDH2

HGVS.p: NP_002159.2:p.Arg172Met

Precision oncology relationships for therapeutic response involving this biomarker.

Organizations	Biomarkers	Cancer types	Therapies
FDA (1)	IDH2 p.R172M	Acute Myeloid Leukemia	Enasidenib
FDA (1) HC (1)	IDH2 p.R172M	Astrocytoma	Vorasidenib
FDA (1) HC (1)	IDH2 p.R172M	Oligodendroglioma	Vorasidenib